Man Tong

13PUBLICATIONS
54CO-AUTHORS
Molecular targetsHaematological tumoursCancer cell biologyCheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 11, 2025
Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma.

Martina Mang Leng Lei, Carmen Oi Ning Leung, Rainbow Wing Hei Leung

|Jul 14, 2025
FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors.

Jiahuan Lu, Thomas Ting-Hei Chan, Yun Wang

|Feb 03, 2024
Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer.

Yunong Xie, Haofeng Wu, Yimiao He

|Jun 10, 2023
Protein Posttranslational Modification in Stemness Remodeling and Its Emerging Role as a Novel Therapeutic Target in Gastrointestinal Cancers.

Yifei Wang, Man Tong

|May 19, 2023
ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer.

Tin-Lok Wong, Jia-Jian Loh, Shixun Lu

|Jan 11, 2023
SERPINA12 promotes the tumorigenic capacity of HCC stem cells through hyperactivation of AKT/β-catenin signaling.

Huajian Yu, Lei Zhou, Jane H C Loong

Pageof 3

Frequent Collaborators

11 joint publications

Stephanie Ma

7 joint publications

Tin-Lok Wong

5 joint publications

Terence Kin Wah Lee

4 joint publications

Jing-Ping Yun